Spelling suggestions: "subject:"dffect off drugs"" "subject:"dffect oof drugs""
201 |
Aerobic Uptake of Cholesterol by Ergosterol Auxotrophic Strains in Candida glabrata & Random and Site-Directed Mutagenesis of ERG25 in Saccharomyces cerevisiaeWhybrew, Jennafer Marie 27 September 2012 (has links)
Indiana University-Purdue University Indianapolis (IUPUI) / Candida albicans and Candida glabrata are opportunistic human pathogens that are the leading cause of fungal infections, which are increasingly becoming the leading cause of sepsis in immunosuppressed individuals. C. glabrata in particular has become a significant concern due to the increase in clinical isolates that demonstrate resistance to triazole antifungal drugs, the most prevalent treatment for such infections. Triazole drugs target the ERG11 gene product and prevent C-14 demethylation of the first sterol intermediate, lanosterol, preventing the production of the pathways end product ergosterol. Ergosterol is required by yeast for cell membrane fluidity and cell signaling. Furthermore, C. glabrata, and not C. albicans, has been reported to utilize cholesterol as a supplement for growth.
Although drug resistance is known to be caused by an increase in expression of drug efflux pumps, we hypothesize a second mechanism: that the overuse of triazole drugs has lead to the increase of resistance by C. glabrata through a 2-step process: 1) the accumulation of ergosterol auxotrophic mutations and 2) mutants able to take up exogenous cholesterol anaerobically in the body acquire a second mutation allowing uptake of cholesterol aerobically. Two groups of sterol auxotrophic C. glabrata clinical isolates have been reported to take up sterol aerobically but do not produce a sterol
precursor. Sterol auxotrophs have been created in C. glabrata by disrupting different essential genes (ERG1, ERG7, ERG11, ERG25, and ERG27) in the ergosterol pathway to assess which ergosterol mutants will take up sterols aerobically.
Random and site-directed mutagenesis was also completed in ERG25 of Saccharmoyces cerevisiae. The ERG25 gene encodes a sterol C-4 methyloxidase essential for sterol biosynthesis in plants, animals, and yeast. This gene functions in turn with ERG26, a sterol C-3 dehydrogenase, and ERG27, a sterol C-3 keto reductase, to remove two methyl groups at the C-4 position on the sterol A ring. In S. cerevisiae, ERG25 has four putative histidine clusters, which bind non-heme iron and a C-terminal KKXX motif, which is a Golgi to ER retrieval motif. We have conducted site-directed and random mutagenesis in the S. cerevisiae wild-type strain SCY876. Site-Directed mutagenesis focused on the four histidine clusters, the KKXX C-terminal motif and other conserved amino acids among various plant, animal, and fungal species. Random mutagenesis was completed with a procedure known as gap repair and was used in an effort to find novel changes in enzyme function outside of the parameters utilized for site-directed mutagenesis. The four putative histidine clusters are expected to be essential for gene function by acting as non-heme iron binding ligands bringing in the oxygen required for the oxidation-reduction in the C-4 demethylation reaction.
|
202 |
A neurodevelopmental profile of infants with Fetal Alcohol Spectrum Disorder (FASD) in the Northern Cape region, South AfricaFourie, Leigh-Anne 30 November 2006 (has links)
Fetal Alcohol Syndrome (FAS) is a preventable cause of mental retardation and is the severest
category within Fetal Alcohol Spectrum Disorder (FASD). As gestational alcohol exposure
affects fetal cognitive functioning, children with FAS present with intellectual deficits.
Unfortunately FASD prevalence rates are increasing amongst infants and school-going
children. The main goal of this study was to compare the neurodevelopmental subscales of
infants diagnosed with FAS, Partial FAS and non- FAS. Seventy-four infants with confirmed
FAS, Partial FAS or Non- FAS diagnoses were assessed using the Griffiths Mental
Developmental Scale.
Development assessed at 7-12 and 17-29 months of age showed that, regardless of a FAS,
PFAS or Non-FAS diagnosis, all infants performed weaker at their assessment at 17-29
months. The Subscales significantly affected included Personal-Social, Eye- Hand
Coordination and Performance. The infants with FAS and PFAS displayed the most marked
developmental delays.
From this study it can be concluded that there are definite neurodevelopmental profiles for
infant's diagnosed with FAS, PFAS and/or Non-FAS, highlighting the significant impact of
prenatal alcohol exposure on various aspects of infant development. / Social work / M.Diac.
|
203 |
A neurodevelopmental profile of infants with Fetal Alcohol Spectrum Disorder (FASD) in the Northern Cape region, South AfricaFourie, Leigh-Anne 30 November 2006 (has links)
Fetal Alcohol Syndrome (FAS) is a preventable cause of mental retardation and is the severest
category within Fetal Alcohol Spectrum Disorder (FASD). As gestational alcohol exposure
affects fetal cognitive functioning, children with FAS present with intellectual deficits.
Unfortunately FASD prevalence rates are increasing amongst infants and school-going
children. The main goal of this study was to compare the neurodevelopmental subscales of
infants diagnosed with FAS, Partial FAS and non- FAS. Seventy-four infants with confirmed
FAS, Partial FAS or Non- FAS diagnoses were assessed using the Griffiths Mental
Developmental Scale.
Development assessed at 7-12 and 17-29 months of age showed that, regardless of a FAS,
PFAS or Non-FAS diagnosis, all infants performed weaker at their assessment at 17-29
months. The Subscales significantly affected included Personal-Social, Eye- Hand
Coordination and Performance. The infants with FAS and PFAS displayed the most marked
developmental delays.
From this study it can be concluded that there are definite neurodevelopmental profiles for
infant's diagnosed with FAS, PFAS and/or Non-FAS, highlighting the significant impact of
prenatal alcohol exposure on various aspects of infant development. / Social work / M.Diac.
|
204 |
Efeito crônico da administração de esteróide anabólico androgênico na próstata de ratos / The prostate after anabolic-androgenic steroids: a morphometrical study ratsRafael Arêas Vargas 27 February 2013 (has links)
Esteróides anabólicos androgênicos (EAA) são usados por atletas profissionais e amadores, com o objetivo de melhorar a capacidade atlética, aparência e massa muscular. Muitos efeitos adversos têm sido associados com o abuso de EAA, incluindo doenças do trato urogenital. Este estudo teve como objetivo avaliar as alterações morfológicas no lobo ventral da próstata de ratos púberes e adultos cronicamente tratados com doses suprafisiológicas de EAA, usando métodos morfométricos. Foram estudados 39 ratos Wistar machos pesando entre 400 e 550 g. Os ratos foram divididos em quatro grupos: (a) ratos controle, com 105 dias de idade (C105) (n = 7); (b) ratos controle com 65 dias de idade (C 65) (n = 9), injectados com o veículo (óleo de amendoim); (c) ratos tratados com 105 dias de idade (T105) (n = 10) e (d) Os ratos tratados com 65 dias de idade (C 65) (n = 13). Os ratos tratados foram injectados com decanoato de nandrolona, numa dose de 10 mg.Kg-1 de peso corporal. O hormônio esteróide e o veículo foram administrados por via intramuscular, uma vez por semana, durante oito semanas. Os ratos foram sacrificados aos 161 dias de idade (C105 e T105) e 121 dias de idade (C65 e T65) e do lóbulo ventral da próstata foi dissecada e processada para histologia. A altura do epitélio acinar foi medida em micrômetros em fotomicrografias com ampliação de 400x. As densidades de superfície do lúmen do epitélio e estroma foram calculadas pelo método de contagem de pontos, com uma grade de 100 pontos sobrepostos sobre imagens ampliadas em 200x. Todas as análises foram realizadas com o software ImageJ. O teste t de Student e ANOVA foram utilizados para a comparação de médias. Foi considerado significativo quando p<0,05. O peso e volume do lobo ventral da próstata mostraram diferenças entre os grupos C65, T65, C105 e T105. A altura do epitélio não mostrou nenhuma diferença entre os grupos C65 e T65 (p = 0,8509), mas o grupo T105 mostrou um aumento de 32% em relação ao C105 (p = 0,0089). No que diz respeito à densidade de superfície do lúmen não houve diferença entre C65 e T65 (p = 0,9031) mas uma diminuição de 19% em relação a T105 em comparação com C105 (p = 0,0061). Não houve diferença na densidade de superfície do epitélio entre C65 e T65 (p = 0,7375), mas o grupo T105 apresentou 51% de aumento (p = 0,0065) em comparação com o C105. Em relação à densidade superficial do estroma, não foram observadas diferenças entre C65 e T65 e entre C105 e T105. Finalmente, não houve diferença no padrão de colágeno entre C105 e T105, mas o grupo T65 mostrou uma predominância de fibras de colágeno tipo I em relação ao C65. A utilização de esteróides androgênicos anabólicos em ratos promove mudanças estruturais na próstata. Observamos mudanças estruturais na altura, volume e epitélio do lobo da ventral da próstata e uma predominância de fibras de colágeno.
|
205 |
Efeito crônico da administração de esteróide anabólico androgênico na próstata de ratos / The prostate after anabolic-androgenic steroids: a morphometrical study ratsRafael Arêas Vargas 27 February 2013 (has links)
Esteróides anabólicos androgênicos (EAA) são usados por atletas profissionais e amadores, com o objetivo de melhorar a capacidade atlética, aparência e massa muscular. Muitos efeitos adversos têm sido associados com o abuso de EAA, incluindo doenças do trato urogenital. Este estudo teve como objetivo avaliar as alterações morfológicas no lobo ventral da próstata de ratos púberes e adultos cronicamente tratados com doses suprafisiológicas de EAA, usando métodos morfométricos. Foram estudados 39 ratos Wistar machos pesando entre 400 e 550 g. Os ratos foram divididos em quatro grupos: (a) ratos controle, com 105 dias de idade (C105) (n = 7); (b) ratos controle com 65 dias de idade (C 65) (n = 9), injectados com o veículo (óleo de amendoim); (c) ratos tratados com 105 dias de idade (T105) (n = 10) e (d) Os ratos tratados com 65 dias de idade (C 65) (n = 13). Os ratos tratados foram injectados com decanoato de nandrolona, numa dose de 10 mg.Kg-1 de peso corporal. O hormônio esteróide e o veículo foram administrados por via intramuscular, uma vez por semana, durante oito semanas. Os ratos foram sacrificados aos 161 dias de idade (C105 e T105) e 121 dias de idade (C65 e T65) e do lóbulo ventral da próstata foi dissecada e processada para histologia. A altura do epitélio acinar foi medida em micrômetros em fotomicrografias com ampliação de 400x. As densidades de superfície do lúmen do epitélio e estroma foram calculadas pelo método de contagem de pontos, com uma grade de 100 pontos sobrepostos sobre imagens ampliadas em 200x. Todas as análises foram realizadas com o software ImageJ. O teste t de Student e ANOVA foram utilizados para a comparação de médias. Foi considerado significativo quando p<0,05. O peso e volume do lobo ventral da próstata mostraram diferenças entre os grupos C65, T65, C105 e T105. A altura do epitélio não mostrou nenhuma diferença entre os grupos C65 e T65 (p = 0,8509), mas o grupo T105 mostrou um aumento de 32% em relação ao C105 (p = 0,0089). No que diz respeito à densidade de superfície do lúmen não houve diferença entre C65 e T65 (p = 0,9031) mas uma diminuição de 19% em relação a T105 em comparação com C105 (p = 0,0061). Não houve diferença na densidade de superfície do epitélio entre C65 e T65 (p = 0,7375), mas o grupo T105 apresentou 51% de aumento (p = 0,0065) em comparação com o C105. Em relação à densidade superficial do estroma, não foram observadas diferenças entre C65 e T65 e entre C105 e T105. Finalmente, não houve diferença no padrão de colágeno entre C105 e T105, mas o grupo T65 mostrou uma predominância de fibras de colágeno tipo I em relação ao C65. A utilização de esteróides androgênicos anabólicos em ratos promove mudanças estruturais na próstata. Observamos mudanças estruturais na altura, volume e epitélio do lobo da ventral da próstata e uma predominância de fibras de colágeno.
|
206 |
Neuropsychological assessment of executive functions in substance dependence populations: a systematic reviewJansen van Vuuren, Jacques 11 1900 (has links)
The role of executive functioning in substance dependence and addiction has received
increased attention in recent years; however, the findings of empirical studies are at times
contradictory and difficult to compare at face value. To address the current state of
fragmentation and to delineate the current body of knowledge a systematic review of
existing studies was conducted. The synthesis of the findings from these studies confirmed
that lower neuropsychological performance scores of executive functioning are observed
in substance dependent populations. Furthermore, the synthesis of the components of these
studies provided a comprehensive overview and revealed a number of critical gaps in the
current body of knowledge. The gaps include limitations concerning specific
demographics of the samples studied (under-representation of females, adolescents, the
elderly, individuals with limited education, and individuals from Africa, Oceania, Asia,
Latin America and the Caribbean), as well as the scarce number of studies investigating
specific substances; insufficient longitudinal studies; and the fragmentation of executive
functioning as a theoretical construct. / Psychology / M.A. (Psychology)
|
207 |
Assessment of the dopamine system in addiction using positron emission tomographyAlbrecht, Daniel Strakis January 2014 (has links)
Indiana University-Purdue University Indianapolis (IUPUI) / Drug addiction is a behavioral disorder characterized by impulsive behavior and continued intake of drug in the face of adverse consequences. Millions of people suffer the financial and social consequences of addiction, and yet many of the current therapies for addiction treatment have limited efficacy. Therefore, there is a critical need to characterize the neurobiological substrates of addiction in order to formulate better treatment options. In the first chapter, the striatal dopamine system is interrogated with [11C]raclopride PET to assess differences between chronic cannabis users and healthy controls. The results of this chapter indicate that chronic cannabis use is not associated with a reduction in striatal D2/D3 receptor availability, unlike many other drugs of abuse. Additionally, recent cannabis consumption in chronic users was negatively correlated with D2/D3 receptor availability. Chapter 2 describes a retrospective analysis in which striatal D2/D3 receptor availability is compared between three groups of alcohol-drinking and tobacco-smoking subjects: nontreatment-seeking alcoholic smokers, social-drinking smokers, and social-drinking non-smokers. Results showed that smokers had reduced D2/D3 receptor availability throughout the striatum, independent of drinking status. The results of the first two chapters suggest that some combustion product of marijuana and tobacco smoke may have an effect on striatal dopamine concentration. Furthermore, they serve to highlight the effectiveness of using baseline PET imaging to characterize dopamine dysfunction in addictions. The final chapter explores the use of [18F]fallypride PET in a proof-of-concept study to determine whether changes in cortical dopamine can be detected during a response inhibition task. We were able to detect several cortical regions of significant dopamine changes in response to the task, and the amount of change in three regions was significantly associated with task performance. Overall, the results of Chapter 3 validate the use of [18F]fallypride PET to detect cortical dopamine changes during a impulse control task. In summary, the results reported in the current document demonstrate the effectiveness of PET imaging as a tool for probing resting and activated dopamine systems in addiction. Future studies will expand on these results, and incorporate additional methods to further elucidate the neurobiology of addiction.
|
208 |
Effect of Epigallocatechin-3-gallate on a pattern separation task and hippocampal neurogenesis in a mouse model of Down syndromeStringer, Megan Elizabeth January 2015 (has links)
Indiana University-Purdue University Indianapolis (IUPUI) / Down syndrome (DS) is caused by three copies of human chromosome 21 (Hsa21) and results in an array of phenotypes including intellectual disability. Ts65Dn mice, the most extensively studied DS model, have three copies of ~50% of the genes on Hsa21 and display many phenotypes associated with DS, including cognitive deficits. DYRK1A is found in three copies in humans with Trisomy 21 and in Ts65Dn mice, and is involved in a number of critical pathways including CNS development and osteoclastogenesis. Epigallocatechin-3-gallate (EGCG), the main polyphenol in green tea, inhibits Dyrk1a activity. We have shown that a three-week EGCG treatment (~10mg/kg/day) during adolescence normalizes skeletal abnormalities in Ts65Dn mice, yet the same dose did not rescue deficits in the Morris water maze spatial learning task (MWM) or novel object recognition (NOR). Others have reported that An EGCG dose of 2-3 mg per day (90mg/ml) improved hippocampal-dependent task deficits in Ts65Dn mice. The current study investigated deficits in a radial arm maze pattern separation task in Ts65Dn mice. Pattern separation requires differentiation between similar memories acquired during learning episodes; distinguishing between these similar memories is thought to depend on distinctive encoding in the hippocampus. Pattern separation has
been linked to functional activity of newly generated granule cells in the dentate gyrus. Recent studies in Ts65Dn mice have reported significant reductions in adult hippocampal neurogenesis, and after EGCG treatment, enhanced hippocampal neurogenesis. Thus, it was hypothesized that Ts65Dn mice would be impaired in the pattern separation task, and that EGCG would alleviate the pattern separation deficits seen in trisomic mice, in association with increased adult hippocampal neurogenesis. At weaning, Ts65Dn mice and euploid littermates were randomly assigned to the water control, or EGCG [0.4 mg/mL], with both treatments yielding average daily intakes of ~50 mg/kg/day. Beginning on postnatal day 75, all mice were trained on a radial arm maze-delayed non-matching-to-place pattern separation task. Euploid mice performed significantly better over training than Ts65Dn mice, including better performance at each of the three separations. EGCG did not significantly alleviate the pattern separation deficits in Ts65Dn mice. After the behavioral testing commenced, animals were given ad libitum food access for five days, received a 100mg/kg injection of BrdU, and were perfused two hours later. Coronal sections through the dorsal hippocampus were processed for BrdU labeling, and cells were manually counted throughout the subgranular zone of the dentate gyrus. The euploid controls had significantly more BrdU labeled cells than Ts65Dn mice, however, EGCG does not appear to increase proliferation of the hippocampal neuroprogenitor cells. This is the first report of deficits in Ts65Dn mice on a pattern separation task. To the extent that pattern separation depends on the functional involvement of newly generated neurons in an adult dentate gyrus, this approach in Ts65Dn mice may help identify more targeted pharmacotherapies for cognitive deficits in individuals with DS.
|
Page generated in 0.0626 seconds